Structures by: Govindhan M.
Total: 5
2-{[(Naphthalen-1-yl)oxy]methyl}-5-(2,4,5-trifluorophenyl)-1,3,4-oxadiazole
C19H11F3N2O2
Acta Crystallographica Section E (2015) 71, 3 o190-o191
a=7.4817(5)Å b=7.5928(5)Å c=15.7908(10)Å
α=78.673(3)° β=78.404(3)° γ=65.370(3)°
2-(4-Fluoro-3-methylphenyl)-5-{[(naphthalen-1-yl)oxy]methyl}-1,3,4-oxadiazole
C20H15FN2O2
Acta Crystallographica Section E (2015) 71, 4 o229-o230
a=7.4236(4)Å b=7.5062(4)Å c=16.3519(8)Å
α=77.092(3)° β=77.494(3)° γ=66.734(3)°
2-(4-{2-[(2-Oxo-2<i>H</i>-chromen-4-yl)oxy]acetyl}piperazin-1-yl)acetamide
C17H19N3O5
Acta Crystallographica Section E (2019) 75, 4 482-488
a=8.5260(3)Å b=8.8415(3)Å c=11.9462(4)Å
α=88.660(2)° β=69.568(2)° γ=70.724(2)°
<i>N</i>-(2,4-Dimethoxybenzyl)-2-[(2-oxo-2<i>H</i>-chromen-4-yl)oxy]acetamide
C20H19NO6
Acta Crystallographica Section E (2019) 75, 4 482-488
a=7.2779(2)Å b=8.5759(3)Å c=14.4099(5)Å
α=90° β=93.796(5)° γ=90°
2-[(2-Oxo-2<i>H</i>-chromen-4-yl)oxy]acetic acid dimethyl sulfoxide monosolvate
C11H8O5,C2H6OS
Acta Crystallographica Section E (2019) 75, 8 1123-1127
a=23.1461(12)Å b=8.2631(4)Å c=14.6374(8)Å
α=90° β=97.687(4)° γ=90°